{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T04:29:47Z","timestamp":1786768187705,"version":"build-2736575974"},"reference-count":46,"publisher":"Pharmaceutical Society of Japan","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2026,8,11]]},"DOI":"10.1248\/bpb.b26-00017","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T22:11:34Z","timestamp":1786399894000},"page":"1240-1249","source":"Crossref","is-referenced-by-count":0,"title":["Innate Immune Modulation &lt;i&gt;via&lt;\/i&gt; TLR3 Activation Suppresses Orthotopic Oral Squamous Cell Carcinoma Growth"],"prefix":"10.1248","volume":"49","author":[{"given":"Muhammad Irfan","family":"Rasul","sequence":"first","affiliation":[{"name":"Department of Comprehensive Oral Science, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama 930\u20130194, Japan"},{"name":"Section of Host Defences, Institute of Natural Medicine, University of Toyama, Toyama 930\u20130194, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"So-Ichiro","family":"Sasaki","sequence":"additional","affiliation":[{"name":"Section of Host Defences, Institute of Natural Medicine, University of Toyama, Toyama 930\u20130194, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidetake","family":"Tachinami","sequence":"additional","affiliation":[{"name":"Department of Comprehensive Oral Science, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama 930\u20130194, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadahiro","family":"Iwabuchi","sequence":"additional","affiliation":[{"name":"Department of Molecular Pathophysiology, Institute of Advanced Medicine, Wakayama Medical University, Wakayama 641\u20130012, Japan"},{"name":"Department of Bioinformatics and Genomics, Graduate School of Medical Sciences, Kanazawa University, Ishikawa 920\u20138640, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Hashimoto","sequence":"additional","affiliation":[{"name":"Department of Molecular Pathophysiology, Institute of Advanced Medicine, Wakayama Medical University, Wakayama 641\u20130012, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Noguchi","sequence":"additional","affiliation":[{"name":"Department of Comprehensive Oral Science, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama 930\u20130194, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Hayakawa","sequence":"additional","affiliation":[{"name":"Section of Host Defences, Institute of Natural Medicine, University of Toyama, Toyama 930\u20130194, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Suzuki S, Ogawa T, Sano R, Takahara T, Inukai D, Akira S, Tsuchida H, Yoshikawa K, Ueda R, Tsuzuki T. Immune-checkpoint molecules on regulatory T-cells as a potential therapeutic target in head and neck squamous cell cancers. <i>Cancer Sci.<\/i>, <b>111<\/b>, 1943\u20131957 (2020).","DOI":"10.1111\/cas.14422"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Neophytou CM, Pierides C, Christodoulou MI, Costeas P, Kyriakou TC, Papageorgis P. The role of tumor-associated myeloid cells in modulating cancer therapy. <i>Front. Oncol.<\/i>, <b>10<\/b>, 899 (2020).","DOI":"10.3389\/fonc.2020.00899"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Lee PY, Wang JX, Parisini E, Dascher CC, Nigrovic PA. Ly6 family proteins in neutrophil biology. <i>J. Leukoc. Biol.<\/i>, <b>94<\/b>, 585\u2013594 (2013).","DOI":"10.1189\/jlb.0113014"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Morikawa N, Tachibana M, Ago Y, Goda H, Sakurai F, Mizuguchi H. LY341495, an mGluR2\/3 antagonist, regulates the immunosuppressive function of myeloid-derived suppressor cells and inhibits melanoma tumor growth. <i>Biol. Pharm. Bull.<\/i>, <b>41<\/b>, 1866\u20131869 (2018).","DOI":"10.1248\/bpb.b18-00055"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Fuse H, Tomihara K, Heshiki W, Yamazaki M, Akyu-takei R, Tachinami H, Furukawa KI, Sakurai K, Rouwan M, Noguchi M. Enhanced expression of PD-L1 in oral squamous cell carcinoma-derived CD11b<sup>+<\/sup>Gr-1<sup>+<\/sup> cells and its contribution to immunosuppressive activity. <i>Oral Oncol.<\/i>, <b>59<\/b>, 20\u201329 (2016).","DOI":"10.1016\/j.oraloncology.2016.05.012"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Tanaka K, Jinhua P, Omura K, Azuma M. Multipotency of CD11b <sup>high<\/sup> Gr-1<sup>+<\/sup> immature myeloid cells accumulating in oral squamous cell carcinoma-bearing mice. <i>Oral Oncol.<\/i>, <b>43<\/b>, 586\u2013592 (2007).","DOI":"10.1016\/j.oraloncology.2006.06.009"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Hu X, Xiang F, Feng Y, Gao F, Ge S, Wang C, Zhang X, Wang N. Neutrophils promote tumor progression in oral squamous cell carcinoma by regulating EMT and JAK2\/STAT3 signaling through chemerin. <i>Front. Oncol.<\/i>, <b>12<\/b>, 812044 (2022).","DOI":"10.3389\/fonc.2022.812044"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Peranzoni E, Zilio S, Marigo I, Dolcetti L, Zanovello P, Mandruzzato S, Bronte V. Myeloid-derived suppressor cell heterogeneity and subset definition. <i>Curr. Opin. Immunol.<\/i>, <b>22<\/b>, 238\u2013244 (2010).","DOI":"10.1016\/j.coi.2010.01.021"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. <i>Nat. Rev. Immunol.<\/i>, <b>9<\/b>, 162\u2013174 (2009).","DOI":"10.1038\/nri2506"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Zhong L, Liu Z, Zhou X, Song S, Weng G, Wen Y, Liu F, Cao D, Liu Y. Expansion of PMN-myeloid derived suppressor cells and their clinical relevance in patients with oral squamous cell carcinoma. <i>Oral Oncol.<\/i>, <b>95<\/b>, 157\u2013163 (2019).","DOI":"10.1016\/j.oraloncology.2019.06.004"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Pang X, Fan HY, Tang YL, Wang SS, Cao MX, Wang HF, Dai LL, Wang K, Yu XH, Wu JB, Tang YJ, Liang XH. Myeloid derived suppressor cells contribute to the malignant progression of oral squamous cell carcinoma. <i>PLOS ONE<\/i>, <b>15<\/b>, 15 (2020).","DOI":"10.1371\/journal.pone.0229089"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. <i>Nature<\/i>, <b>454<\/b>, 436\u2013444 (2008).","DOI":"10.1038\/nature07205"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Takeuchi O, Akira S. Pattern recognition receptors and inflammation. <i>Cell<\/i>, <b>140<\/b>, 805\u2013820 (2010).","DOI":"10.1016\/j.cell.2010.01.022"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Duan T, Du Y, Xing C, Wang HY, Wang RF. Toll-like receptor signaling and its role in cell-mediated immunity. <i>Front. Immunol.<\/i>, <b>13<\/b>, 812774 (2022).","DOI":"10.3389\/fimmu.2022.812774"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. <i>Cell<\/i>, <b>124<\/b>, 783\u2013801 (2006).","DOI":"10.1016\/j.cell.2006.02.015"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Sharma Y, Bala K. Role of Toll like receptor in progression and suppression of oral squamous cell carcinoma. <i>Oncol. Rev.<\/i>, <b>14<\/b>, 80\u201385 (2020).","DOI":"10.4081\/oncol.2020.456"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Tachinami H, Nishii N, Xia Y, Kashima Y, Ohno T, Nagai S, Li L, Lau W, Tomihara K, Noguchi M, Azuma M. Differences of tumor-recruiting myeloid cells in murine squamous cell carcinoma influence the efficacy of immunotherapy combined with a TLR7 agonist and PD-L1 blockade. <i>Oral Oncol.<\/i>, <b>91<\/b>, 21\u201328 (2019).","DOI":"10.1016\/j.oraloncology.2019.02.014"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Muresan XM, Bouchal J, Culig Z, Sou\u010dek K. Toll-like receptor 3 in solid cancer and therapy resistance. <i>Cancers<\/i>, <b>12<\/b>, 3227 (2020).","DOI":"10.3390\/cancers12113227"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Luo Q, Hu S, Yan M, Sun Z, Chen W, Chen F. Activation of Toll-like receptor 3 induces apoptosis of oral squamous carcinoma cells <i>in vitro<\/i> and <i>in vivo<\/i>. <i>Int. J. Biochem. Cell Biol<\/i>., <b>44<\/b>, 1266\u20131275 (2012).","DOI":"10.1016\/j.biocel.2012.04.025"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Park JH, Jeon DI, Yoon HE, Kwon SM, Kim SA, Ahn SG, Yoon JH. Poly I:C inhibits cell proliferation and enhances the growth inhibitory effect of paclitaxel in oral squamous cell carcinoma. <i>Acta Odontol. Scand.<\/i>, <b>70<\/b>, 241\u2013245 (2012).","DOI":"10.3109\/00016357.2011.640278"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Chuang HC, Huang CC, Chien CY, Chuang JH. Toll-like receptor 3-mediated tumor invasion in head and neck cancer. <i>Oral Oncol.<\/i>, <b>48<\/b>, 226\u2013232 (2012).","DOI":"10.1016\/j.oraloncology.2011.10.008"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Dajon M, Iribarren K, Cremer I. Toll-like receptor stimulation in cancer: a pro- and anti-tumor double-edged sword. <i>Immunobiology<\/i>, <b>222<\/b>, 89\u2013100 (2017).","DOI":"10.1016\/j.imbio.2016.06.009"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Oweida AJ, Bhatia S, van Court B, Darragh L, Serkova N, Karam SD. Intramucosal inoculation of squamous cell carcinoma cells in mice for tumor immune profiling and treatment response assessment. <i>J. Vis. Exp.<\/i>, <b>2019<\/b>, 1\u20138 (2019).","DOI":"10.3791\/59195-v"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Ogura K, Sato-Matsushita M, Yamamoto S, Hori T, Sasahara M, Iwakura Y, Saiki I, Tahara H, Hayakawa Y. NK cells control tumor-promoting function of neutrophils in mice. <i>Cancer Immunol. Res.<\/i>, <b>6<\/b>, 348\u2013357 (2018).","DOI":"10.1158\/2326-6066.CIR-17-0204"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Umansky V, Adema GJ, Baran J, Brandau S, Van Ginderachter JA, Hu X, Jablonska J, Mojsilovic S, Papadaki HA, Pico de Coa\u00f1a Y, Santegoets KCM, Santibanez JF, Serre K, Si Y, Sieminska I, Velegraki M, Fridlender ZG. Interactions among myeloid regulatory cells in cancer. <i>Cancer Immunol. Immunother.<\/i>, <b>68<\/b>, 645\u2013660 (2019).","DOI":"10.1007\/s00262-018-2200-6"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Masucci MT, Minopoli M, Carriero MV. Tumor associated neutrophils. their role in tumorigenesis, metastasis, prognosis and therapy. <i>Front. Oncol.<\/i>, <b>9<\/b>, 1146 (2019).","DOI":"10.3389\/fonc.2019.01146"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) MaruYama T, Chen W, Shibata H. TGF-\u03b2 and cancer immunotherapy. <i>Biol. Pharm. Bull.<\/i>, <b>45<\/b>, 155\u2013161 (2022).","DOI":"10.1248\/bpb.b21-00966"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Iwasaki A, Medzhitov R. Toll-like receptor control of the adaptive immune responses. <i>Nat. Immunol.<\/i>, <b>5<\/b>, 987\u2013995 (2004).","DOI":"10.1038\/ni1112"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Pylaeva E, Lang S, Jablonska J. The essential role of type I interferons in differentiation and activation of tumor-associated neutrophils. <i>Front. Immunol.<\/i>, <b>7<\/b>, 629 (2016).","DOI":"10.3389\/fimmu.2016.00629"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Alicea-Torres K, Sanseviero E, Gui J, Chen J, Veglia F, Yu Q, Donthireddy L, Kossenkov A, Lin C, Fu S, Mulligan C, Nam B, Masters G, Denstman F, Bennett J, Hockstein N, Rynda-Apple A, Nefedova Y, Fuchs SY, Gabrilovich DI. Immune suppressive activity of myeloid-derived suppressor cells in cancer requires inactivation of the type I interferon pathway. <i>Nat. Commun.<\/i>, <b>12<\/b>, 1717 (2021).","DOI":"10.1038\/s41467-021-22033-2"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Shime H, Matsumoto M, Oshiumi H, Tanaka S, Nakane A, Iwakura Y, Tahara H, Inoue N, Seya T. Toll-like receptor 3 signaling converts tumor supporting myeloid cells to tumoricidal effectors. <i>Proc. Natl. Acad. Sci. U.S.A.<\/i>, <b>109<\/b>, 2066\u20132071 (2012).","DOI":"10.1073\/pnas.1113099109"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Dumont FJ, Palfree RG, Coker LZ. Phenotypic changes induced by interferon in resting T cells: major enhancement of Ly-6 antigen expression. <i>J. Immunol.<\/i>, <b>137<\/b>, 201\u2013210 (1986).","DOI":"10.4049\/jimmunol.137.1.201"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Shaul ME, Fridlender ZG. Tumor-associated neutrophils in patients with cancer. <i>Nat. Rev. Clin. Oncol.<\/i>, <b>16<\/b>, 601\u2013620 (2019).","DOI":"10.1038\/s41571-019-0222-4"},{"key":"34","unstructured":"34) Veglia F, Sanseviero E, Gabrilovich DI. Myeloid-derived suppressor cells in cancer. <i>J. Exp. Med.<\/i>, <b>39<\/b>, 311\u2013336 (2021)."},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Kumar S, Mitnik C, Valente G, Floyd-Smith G. Expansion and molecular evolution of the interferon-induced 2\u2032-5\u2032 oligoadenylate synthetase gene family. <i>Mol. Biol. Evol.<\/i>, <b>17<\/b>, 738\u2013750 (2000).","DOI":"10.1093\/oxfordjournals.molbev.a026352"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Salo T, Vered M, Bello IO, Nyberg P, Bitu CC, Zlotogorski Hurvitz A, Dayan D. Insights into the role of components of the tumor microenvironment in oral carcinoma call for new therapeutic approaches. <i>Exp. Cell Res.<\/i>, <b>325<\/b>, 58\u201364 (2014).","DOI":"10.1016\/j.yexcr.2013.12.029"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Hoffstein ST, Weissmann G, Pearlstein E. Fibronectin is a component of the surface coat of human neutrophils. <i>J. Cell Sci.<\/i>, <b>50<\/b>, 315\u2013327 (1981).","DOI":"10.1242\/jcs.50.1.315"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) La Fleur M, Beaulieu AD, Kreis C, Poubelle P. Fibronectin gene expression in polymorphonuclear leukocytes. Accumulation of mRNA in inflammatory cells. <i>J. Biol. Chem.<\/i>, <b>262<\/b>, 2111\u20132115 (1987).","DOI":"10.1016\/S0021-9258(18)61624-2"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Monti M, Iommelli F, De Rosa V, Carriero MV, Miceli R, Camerlingo R, Di Minno G, Del Vecchio S. Integrin-dependent cell adhesion to neutrophil extracellular traps through engagement of fibronectin in neutrophil-like cells. <i>PLOS ONE<\/i>, <b>12<\/b>, e0171362 (2017).","DOI":"10.1371\/journal.pone.0171362"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Boutt\u00e9 AM, Friedman DB, Bogyo M, Min Y, Yang L, Lin PC. Identification of a myeloid-derived suppressor cell cystatin-like protein that inhibits metastasis. <i>FASEB J.<\/i>, <b>25<\/b>, 2626\u20132637 (2011).","DOI":"10.1096\/fj.10-180604"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Tsai SH, Kinoshita M, Kusu T, Kayama H, Okumura R, Ikeda K, Shimada Y, Takeda A, Yoshikawa S, Obata-Ninomiya K, Kurashima Y, Sato S, Umemoto E, Kiyono H, Karasuyama H, Takeda K. The ectoenzyme E-NPP3 negatively regulates ATP-dependent chronic allergic responses by basophils and mast cells. <i>Immunity<\/i>, <b>42<\/b>, 279\u2013293 (2015).","DOI":"10.1016\/j.immuni.2015.01.015"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42) Mao H, Han B, Li H, Tao Y, Wu W. FABP4 knockdown suppresses inflammation, apoptosis and extracellular matrix degradation in IL-1\u03b2-induced chondrocytes by activating PPAR\u03b3 to regulate the NF-\u03baB signaling pathway. <i>Mol. Med. Rep.<\/i>, <b>24<\/b>, 855 (2021).","DOI":"10.3892\/mmr.2021.12495"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43) Haick AK, Rzepka JP, Brandon E, Balemba OB, Miura TA. Neutrophils are needed for an effective immune response against pulmonary rat coronavirus infection, but also contribute to pathology. <i>J. Gen. Virol.<\/i>, <b>95<\/b>, 578\u2013590 (2014).","DOI":"10.1099\/vir.0.061986-0"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44) Lim K, Hyun YM, Lambert-Emo K, Capece T, Bae S, Miller R, Topham DJ, Kim M. Neutrophil trails guide influenza-specific CD8<sup>+<\/sup> T cells in the airways. <i>Science<\/i>, <b>349<\/b>, aaa4352 (2015).","DOI":"10.1126\/science.aaa4352"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45) Niu X, Tang L, Tseggai T, Guo Y, Fu ZF. Wild-type rabies virus phosphoprotein is associated with viral sensitivity to type I interferon treatment. <i>Arch. Virol.<\/i>, <b>158<\/b>, 2297\u20132305 (2013).","DOI":"10.1007\/s00705-013-1743-2"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46) Wang YX, Niklasch M, Liu T, Wang Y, Shi B, Yuan W, Baumert TF, Yuan Z, Tong S, Nassal M, Wen YM. Interferon-inducible MX2 is a host restriction factor of hepatitis B virus replication. <i>J. Hepatol.<\/i>, <b>72<\/b>, 865\u2013876 (2020).","DOI":"10.1016\/j.jhep.2019.12.009"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/49\/8\/49_b26-00017\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T04:21:25Z","timestamp":1786767685000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/49\/8\/49_b26-00017\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,11]]},"references-count":46,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b26-00017","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,11]]},"article-number":"b26-00017"}}